According to the American Cancer Society, prostate cancer is the second-leading cause of cancer-related death in males in the United States, behind only lung cancer. Around 1 out of every 8 men will be diagnosed with prostate cancer at some point in their lives. In most cases, it is treatable, yet there are some cases where all known therapies are met with resistance and things take a turn for the worse. However, a new study involving mouse models revealed that a precursor to vitamin K can potentially slow prostate cancer growth.
Groundbreaking Study on Vitamin K and Cancer
researchers in a lab
Credit: Pexels
A recent discovery at Cold Spring Harbor Laboratory potentially offers a novel solution to the prostate cancer issue. Professor Lloyd Trotman and his team have discovered that the pro-oxidant supplement menadione reduces the development of prostate cancer in studies involving mice. Menadione is found in leafy greens and is a precursor to vitamin K. While this study itself is new, it is the result of another study that took place at the beginning of this century.
ADVERTISEMENT
Ground Beef And Peppers Skillet
How To Make Roasted Garlic Parmesan Cauliflower
Discover the Natural Secret to Radiant Skin: Honey and Water
Homemade Turtle Candy With Pecans and Caramel
Important to Know!
Sumptuous Chicken Club Pasta Salad Delight
Don’t throw away cardboard rolls anymore, what you get from them is valuable if you do this
Why Were Olympic Athletes & Other Celebs Spotted with Dark Red Circles on Their Bodies?
Leaky and Dripping Faucet
